Children (4 to 11 years of age) who weigh 30 kg or more in the treatment of partial seizures:
The recommended initial dose is 2 mg (4 ml) once a day before bedtime.
Your doctor may increase this dose in increments of 2 mg (4 ml) up to a maintenance dose between 4 mg (8 ml) and 8 mg (16 ml), depending on your response. Depending on clinical response and tolerability, the dose may be increased to a maximum of 12 mg/day (24 ml/day).
If you have mild or moderate liver problems, your dose should not exceed 4 mg (8 ml) per day and dose increases should be made with an interval of at least 2 weeks.
Do not take more Fycompa than recommended by your doctor. It may take several weeks to find the right dose of Fycompa for you.
Children (4 to 11 years of age) who weigh 20 kg to less than 30 kg in the treatment of partial seizures:
The recommended initial dose is 1 mg (2 ml) once a day before bedtime.
Your doctor may increase this dose in increments of 1 mg (2 ml) up to a maintenance dose between 4 mg (8 ml) and 6 mg (12 ml), depending on your response. Depending on clinical response and tolerability, the dose may be increased to a maximum of 8 mg/day (16 ml/day).
If you have mild or moderate liver problems, your dose should not exceed 4 mg (8 ml) per day and dose increases should be made with an interval of at least 2 weeks.
Do not take more Fycompa than recommended by your doctor. It may take several weeks to find the right dose of Fycompa for you.
Children (4 to 11 years of age) who weigh less than 20 kg in the treatment of partial seizures:
The recommended initial dose is 1 mg (2 ml) once a day before bedtime.
Your doctor may increase this dose in increments of 1 mg up to a maintenance dose between 2 mg (4 ml) and 4 mg (8 ml), depending on your response. Depending on clinical response and tolerability, the dose may be increased to a maximum of 6 mg/day (12 ml/day).
If you have mild or moderate liver problems, your dose should not exceed 4 mg (8 ml) per day and dose increases should be made with an interval of at least 2 weeks.
Do not take more Fycompa than recommended by your doctor. It may take several weeks to find the right dose of Fycompa for you.
Children (7 to 11 years of age) who weigh 30 kg or more in the treatment of generalized seizures:
The recommended initial dose is 2 mg (4 ml) once a day before bedtime.
Your doctor may increase this dose in increments of 2 mg (4 ml) up to a maintenance dose between 4 mg (8 ml) and 8 mg (16 ml), depending on your response. Depending on clinical response and tolerability, the dose may be increased to a maximum of 12 mg/day (24 ml/day).
If you have mild or moderate liver problems, your dose should not exceed 4 mg (8 ml) per day and dose increases should be made with an interval of at least 2 weeks.
Do not take more Fycompa than recommended by your doctor. It may take several weeks to find the right dose of Fycompa for you.
Children (7 to 11 years of age) who weigh 20 kg to less than 30 kg in the treatment of generalized seizures:
The recommended initial dose is 1 mg (2 ml) once a day before bedtime.
Your doctor may increase this dose in increments of 1 mg (2 ml) up to a maintenance dose between 4 mg (8 ml) and 6 mg (12 ml), depending on your response. Depending on clinical response and tolerability, the dose may be increased to a maximum of 8 mg/day (16 ml/day).
If you have mild or moderate liver problems, your dose should not exceed 4 mg (8 ml) per day and dose increases should be made with an interval of at least 2 weeks.
Do not take more Fycompa than recommended by your doctor. It may take several weeks to find the right dose of Fycompa for you.
Children (7 to 11 years of age) who weigh less than 20 kg in the treatment of generalized seizures:
The recommended initial dose is 1 mg (2 ml) once a day before bedtime.
Your doctor may increase this dose in increments of 1 mg up to a maintenance dose between 2 mg (4 ml) and 4 mg (8 ml), depending on your response. Depending on clinical response and tolerability, the dose may be increased to a maximum of 6 mg/day (12 ml/day).
If you have mild or moderate liver problems, your dose should not exceed 4 mg (8 ml) per day and dose increases should be made with an interval of at least 2 weeks.
Do not take more Fycompa than recommended by your doctor. It may take several weeks to find the right dose of Fycompa for you.
How to take
Fycompa is administered orally. Fycompa can be taken with or without food and should be taken in the same way every time. For example, if you decide to take Fycompa with food, take it with food every time.
Use the oral syringe and adapter provided for administration.
Below are the instructions for use of the oral syringe and adapter:
1.Shake well before use.
2.Press and (1) turn the cap (2) to open the bottle.
3.Insert the adapter into the neck of the bottle until it is securely closed.
4.Insert the plunger of the syringe completely.
5.Insert the syringe into the opening of the adapter as far as possible.
6.Place the bottle upside down and extract the prescribed amount of Fycompa.
7.Place the bottle right side up and remove the syringe.
8.Leave the adapter in place and replace the cap on the bottle.
9.After administering the dose, separate the body and plunger and submerge them completely in warm soapy water.
10.Submerge the body and plunger in water to remove detergent residue, shake off excess water, and let air dry. Do not manually dry the dispensers.
11.Do not clean or reuse the syringe after 40 uses or if the syringe marks are erased when washing.
.
If you take more Fycompa than you should
If you have taken more Fycompa than you should, consult your doctor immediately. You may experience drowsiness, agitation, aggressive behavior, and decreased level of consciousness.
If you forget to take Fycompa
-If you forget to take Fycompa, wait until it is time to take the next dose and continue as usual.
-Do not take a double dose to make up for the missed doses.
-If you have missed less than 7 days of Fycompa treatment, continue taking the daily dose as originally indicated by your doctor.
-If you have missed more than 7 days of Fycompa treatment, consult your doctor immediately.
If you interrupt Fycompa treatment
Take Fycompa for the recommended time by your doctor. Do not interrupt treatment unless your doctor advises you to. Your doctor may gradually reduce your dose to prevent seizures from returning or worsening.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
4. Possible Adverse Effects
Like all medications, this medication may cause side effects, although not everyone will experience them.
A reduced number of people taking antiepileptic medications have had thoughts of self-harm or suicide. If, at any time, you have these thoughts, consult your doctor immediately.
Very common(may affect more than 1in 10users):
-dizziness
-drowsiness (drowsiness or somnolence)
Common(may affect up to 1in 10users):
-increased or decreased appetite, weight gain
-feeling of aggression, anger, irritability, anxiety, or confusion
-difficulty walking or other balance problems (ataxia, gait disorder, balance disorder)
-slow speech (dysarthria)
-blurred vision or double vision (diplopia)
-feeling that everything is spinning (vertigo)
-nausea (gag reflex)
-back pain
-feeling extremely tired (fatigue)
-falls
Rare(may affect up to 1in 100users):
-thoughts of self-harm or suicide, attempt to end life (suicide attempt)
-hallucinations (seeing, hearing, or feeling things that do not exist)
-abnormal thoughts or loss of contact with reality (psychotic disorder)
Unknown frequency(the frequency of this side effect cannot be estimated from available data):
Drug reaction with eosinophilia and systemic symptoms, also known as DRESS syndrome or drug hypersensitivity syndrome: generalized rash, elevated body temperature, elevated liver enzymes, blood abnormalities (eosinophilia), lymph node swelling, and involvement of other body organs.
Stevens-Johnson syndrome, SSJ. This severe skin rash may appear as red spots with a target shape or as circular patches, often with blisters in the center, located on the trunk; skin peeling, mouth, throat, nose, genital, and eye ulcers, and may be preceded by fever and flu-like symptoms.
Stop using perampanel if any of these symptoms appear and consult your doctor or seek immediate medical attention. See also section2.
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through theSistema Español de Farmacovigilancia de medicamentos de Uso Humanowww.notificaRAM.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
5. Conservation of Fycompa
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the label of the bottle and on the box. The expiration date is the last day of the month indicated.
No special storage conditions are required.
If more than 90days have passed since the first opening, do not use the remaining suspension in the bottle.
Medications should not be thrown away through drains or in the trash. Ask your pharmacist how to dispose of the containers and medications that you no longer need. In this way, you will help protect the environment.
6. Contents of the packaging and additional information
Composition of Fycompa
The active ingredient is perampanel. Each milliliter contains 0.5 mg of perampanel.
The other components are sorbitol (E420) liquid (crystallizing), microcrystalline cellulose (E460), sodium carboxymethylcellulose (E466), poloxamer 188, simethicone emulsion at 30% (contains purified water, silicone oil, polysorbate 65, methylcellulose, silica gel, stearyl macrogol, citric acid anhydrous (E330), sodium benzoate (E211), and sulfuric acid), citric acid anhydrous (E330), sodium benzoate (E211), and purified water.
Appearance of the product and contents of the package
Fycompa 0.5 mg/ml oral suspension is a white to off-white suspension. It is presented in a 340 ml bottle with 2 oral syringes graduated for use and a pressure bottle adapter (PIBA).
Информация носит справочный характер и не является медицинской рекомендацией. Перед приёмом любых препаратов проконсультируйтесь с врачом. Oladoctor не несёт ответственности за медицинские решения, принятые на основе этого контента.
Общайтесь с врачом онлайн
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.